AYTU offering history
Every offering-related filing in AYTU BIOPHARMA, INC’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 903 filings back to Jan 11, 2007.
| Date | Filing | What it means | |
|---|---|---|---|
| Apr 2, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 9, 2025 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 6, 2025 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Jun 5, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 5, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 2, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Oct 15, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 11, 2024 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Sep 26, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 12, 2023 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 9, 2023 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jun 8, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 6, 2023 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jun 5, 2023 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 1, 2023 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Nov 14, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 10, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 8, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 22, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 8, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 4, 2022 | 424B2 → | EXECUTED | Prospectus supplement priced — shares or notes (large filers: often a bond deal) |
| Mar 3, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 31, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 4, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 7, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Sep 28, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 7, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 7, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 9, 2021 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 9, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 14, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 11, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Dec 10, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Dec 10, 2020 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jul 2, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 17, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 17, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 8, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Apr 3, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 20, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
AYTU offering FAQ
When did AYTU last execute an offering?
Per SEC filings, AYTU BIOPHARMA, INC's most recent priced offering document is a 8-K filed 2026-04-02. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did AYTU last announce or register an offering?
The most recent registration is a S-1MEF filed 2025-06-06. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.